Health Condition 1: null- Non erosive gastro-esophageal reflux disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ï?§ Patient presenting with heartburn & regurgitation with symptom score of more than 4 with normal endoscopic finding. ï?§ Patient having history of heart burn & regurgitation for 6 weeks with minimum of 2 episodes in a week.
Exclusion criteria
Exclusion criteria: ï?§ Pregnancy or lactation period. ï?§ Patients having: ï?¼ Dysphagia or associated alarm symptoms like gastrointestinal hemorrhage, mechanical obstruction or perforation. ï?¼ Peptic ulcer disease. ï?¼ Severe cardiac, pulmonary, hepatic or renal disease. ï?¼ Presence of gall stone disease. ï?§ Patient on concomitant medications known to affect the treatment response or recent h/o consumption of systemic glucocorticoids or non-steroidal anti-inflammatory drugs (NSAIDs), Proton Pump Inhibitors and histamine 2-receptor antagonists within the previous 15 days. ï?§ Patients with history of previous surgery of gastrointestinal tract excluding appendectomy, cholecystectomy and polypectomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ï?§ Improvement in GERD -based symptom score from baseline to end of treatment. ï?§ Resolution of symptoms in terms of severity and frequency. ï?§ To assess the quality of life by WHO-QOL BREF. Timepoint: the outcome will be assessed at 56th week(at the end of treatment) | — |
Secondary
| Measure | Time frame |
|---|---|
| To deduce symptom of the drugs found effective.Timepoint: At the end of study | — |
Countries
India
Contacts
Central Council for Research in Homoeopathy